Synosia Therapeutics News
Most Popular Synosia Therapeutics Story
Emerging Drug Developer: Synosia Therapeutics
Synosia relies on relationships to grow fast Back in 2005, Synosia Therapeutics was little more than a gleam in a venture capitalist's eye. Bradley Bolzon, an experienced biotech player and an Read more...
Latest Headlines
- January 11, 2011
- October 12, 2010
- January 7, 2009
- July 28, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
